Literature DB >> 9184189

Comparison of the diagnosis of leukaemia from death certificates, cancer registration and histological reports - implications for occupational case-control studies.

L Rushton1, H Romaniuk.   

Abstract

It is essential in occupational case-control studies of rare diseases for ascertainment to be as complete as possible, together with an accurately defined diagnosis. A nested case-control study from a large cohort of UK oil distribution workers followed up since 1950 was carried out to investigate the association between leukaemia, in particular acute myeloid leukaemia, and exposure to benzene. Ninety-one cases occurring before 1993 were identified from death certificates or cancer registrations (available from 1971). Histopathology departments were contacted to obtain material that might confirm the diagnosis of leukaemia and this was received for 39 (43%) cases. The majority of the cases (88) were identified primarily from death certificates, with a cancer registration also being received for 56 (90%) of the 62 deaths occurring after 1971. Discrepancies in the diagnoses from these two sources were found for 12 cases, five being acute myeloid leukaemia. For the majority, the diagnosis on the death certificate was more specific than that on the cancer registration. Histology reports were received for nine of the discrepancies, all confirming the death certificate diagnosis. Although leukaemia appears to be regularly registered as a cancer, records may not be routinely updated when new clinical information becomes available. It is recommended that death certificates, cancer registrations and histology reports are obtained routinely by cancer registries to maximize both numbers of cases and diagnostic accuracy for epidemiological studies.

Entities:  

Mesh:

Year:  1997        PMID: 9184189      PMCID: PMC2223519          DOI: 10.1038/bjc.1997.288

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Leukemia associated with benzene exposure.

Authors:  E C Vigliani
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  Retrospective estimation of exposure to benzene in a leukaemia case-control study of petroleum marketing and distribution workers in the United Kingdom.

Authors:  S J Lewis; G M Bell; N Cordingley; E D Pearlman; L Rushton
Journal:  Occup Environ Med       Date:  1997-03       Impact factor: 4.402

3.  The validity of a cancer register in leukaemia epidemiology.

Authors:  C Bowie
Journal:  Community Med       Date:  1987-05

4.  Epidemiological survey of oil distribution centres in Britain.

Authors:  L Rushton; M R Alderson
Journal:  Br J Ind Med       Date:  1983-08

Review 5.  Carcinogenicity of benzene, toluene and xylene: epidemiological and experimental evidence.

Authors:  A J McMichael
Journal:  IARC Sci Publ       Date:  1988

6.  Making cancer statistics more informative: measures of the quality of recorded diagnosis in a population-based registry.

Authors:  P B Silcocks; H Thornton-Jones; R G Skeet
Journal:  Eur J Cancer Clin Oncol       Date:  1989-10

7.  Benzene and leukemia. An epidemiologic risk assessment.

Authors:  R A Rinsky; A B Smith; R Hornung; T G Filloon; R J Young; A H Okun; P J Landrigan
Journal:  N Engl J Med       Date:  1987-04-23       Impact factor: 91.245

8.  An update of mortality among chemical workers exposed to benzene.

Authors:  G G Bond; E A McLaren; C L Baldwin; R R Cook
Journal:  Br J Ind Med       Date:  1986-10

9.  Myeloid leukaemia in Scotland.

Authors:  I W Kemp; G J Stein; M A Heasman
Journal:  Lancet       Date:  1980-10-04       Impact factor: 79.321

Review 10.  Hematotoxicity and carcinogenicity of benzene.

Authors:  M Aksoy
Journal:  Environ Health Perspect       Date:  1989-07       Impact factor: 9.031

View more
  1 in total

1.  Concordance on the recording of cancer in the Saskatchewan Cancer Agency Registry, hospital charts and death registrations.

Authors:  N S Rawson; D L Robson
Journal:  Can J Public Health       Date:  2000 Sep-Oct
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.